Yatırımcı.AI

ECILC vs EPLAS Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and EPLAS side by side.

ECILCEPLAS
StockFund

If you had invested TRY 10,000

Metric comparison

ECILC vs EPLAS Comparison
MetricECILCEPLASSector median
Last price (TL)63.605.2418.72
Daily change−7.15%−7.75%−4.95%
Market capTRY 43.6BTRY 998.8MTRY 4.4B
P/B0.680.271.14
Dividend yield2.04%—0.90%
Return on equity−3.08%−2.83%1.78%
Free float22.02%71.65%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the ECILC vs EPLAS comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and EPLAS (Egeplast) side by side as of Sep 28, 2026, 12:58. Of the 15 metrics compared, ECILC leads in 7 and EPLAS leads in 8.

Highlights: Daily change: ECILC leads (−7.15% vs −7.75%). Market cap: ECILC leads (TRY 43.6B vs TRY 998.8M). P/B: EPLAS leads (0.27 vs 0.68). EV/EBITDA: EPLAS leads (14.65 vs 165.19). EV/Sales: EPLAS leads (1.01 vs 9.35). Gross margin: ECILC leads (37.83% vs 24.44%). EBITDA margin (annual): ECILC leads (11.49% vs 9.01%). Net margin (annual): EPLAS leads (−4.36% vs −20.86%).

Frequently asked questions

By P/E, Tie is cheaper (— vs —); by P/B, EPLAS trades at the lower multiple (0.68 vs 0.27).

Annual net margin is −20.86% for ECILC and −4.36% for EPLAS; return on equity is −3.08% for ECILC and −2.83% for EPLAS.

The leverage ratio is 18.92 for ECILC and 34.25 for EPLAS; net debt/EBITDA is 1.37 for ECILC and 0.98 for EPLAS. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.